Mirati Therapeutics, Inc. Net Profit Margin 2013-2023 | MRTX
Mirati Therapeutics, Inc. net profit margin from 2013 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-09-30 | $0.04B | $-0.73B | -1910.53% |
| 2023-06-30 | $0.03B | $-0.74B | -2733.33% |
| 2023-03-31 | $0.02B | $-0.74B | -4094.44% |
| 2022-12-31 | $0.01B | $-0.74B | -6166.67% |
| 2022-09-30 | $0.01B | $-0.74B | -6709.09% |
| 2022-06-30 | $0.08B | $-0.64B | -825.64% |
| 2021-09-30 | $0.07B | $-0.48B | -652.70% |
| 2020-12-31 | $0.01B | $-0.36B | -2753.85% |
| 2020-09-30 | $0.01B | $-0.33B | -2741.67% |
| 2020-03-31 | $0.00B | $-0.26B | -8633.33% |
| 2019-12-31 | $0.00B | $-0.21B | -5325.00% |
| 2019-09-30 | $0.01B | $-0.17B | -2816.67% |
| 2018-12-31 | $0.01B | $-0.10B | -825.00% |
